VeriSee DR is a Thailand FDA-approved diagnostic software for diabetic retinopathy (DR). It uses AI and assists healthcare professionals to analyze retinal images for signs of DR. The patient will receive immediate feedback on whether he/she should be referred to an ophthalmologist, or that he/she should come back for routine annual screening. VeriSee DR has a screening accuracy of 93%, which is comparable to ophthalmologists. It is an effective solution that can shorten the screening process, increase the volume of screenings, improve the accuracy and consistency of the results, reduce costs, and most importantly, improve patient outcomes.
Communication and Information Technology | Electromedical Equipment / Medical Technology | Ophthalmic Supplies